Content Type: Article

  • Proposed Federal Contractor Rule Will Impose Pay Equity and Transparency

    Proposed Federal Contractor Rule Will Impose Pay Equity and Transparency

    ARTICLE / CLIENT ALERT

    Proposed Federal Contractor Rule Will Impose Pay Equity and Transparency

    May 17, 2024

    Read time: 6 min

    Key takeaways
    Overview

    There are proposed amendments to the Federal Acquisition Regulation (FAR) that will change employment practices for federal contractors in two ways. First, these amendments will prohibit federal contractors from seeking and considering information about job applicants’ compensation history when making employment decisions. Second, these amendments will require federal contractors to disclose the compensation in job postings for applicable positions.

    The proposed amendments would align with and, in some cases, expand parallel requirements under a patchwork of state and local laws. Public comments on these proposals concluded on April 1, 2024; final approval and official implementation of this proposed rule is expected soon.

    In depth

    States began limiting employers’ right to seek pay history in 2017. Today, more than half of all states have such laws, varying from prohibiting the employer from requesting the information to banning relying on the information, even if volunteered by the applicant. At their core, these laws aim to reduce gender- and race-based pay disparities and promote equal compensation for comparable work.

    Similarly, since 2020, states have passed additional laws requiring disclosure of the compensation anticipated for the job position. So far, 11 states (and a few localities) impose this “transparency” requirement, a trend that will continue to spread. The goal of such laws is to promote equal compensation by arming workers with information to better negotiate their compensation.

    The FAR proposed rule mirrors these state law trends to ensure pay equity. These amendments will create a standard applicable to federal contractors and their subcontractors that not only bans compensation history inquiries but also requires compensation disclosure in job postings.

    Given this trend toward pay transparency, contractors should also consider conducting a pay equity audit in partnership with legal counsel. Such audits assess the distribution of pay among employees performing equal or comparable work to determine if statistically significant disparities exist while controlling for factors that impact pay (e.g., experience, seniority, geography). Those audits provide the opportunity to improve their pay practices through remediation as well as better manage any potential legal risks.

    Rule Requirements

    While proposed as a single rule, this proposal entails two separate components: (i) a prohibition on compensation history inquiries and (ii) a requirement for compensation disclosure.

    A. Compensation History Ban

    The proposed rule would prohibit contractors from requiring disclosure of compensation history as a condition of an applicant’s candidacy. It would also prohibit retaliation against applicants for failing to respond to an inquiry about compensation history.

    Compensation under the proposed rule is defined broadly, expanding beyond just salary and wages to include overtime, shift differentials, bonuses, commissions, vacation and holiday pay, allowances, insurance, other benefits, stock options, profit sharing, and retirement.

    Contractors are prohibited from requiring, or even seeking, this information in writing or orally directly from the applicant or retaliating against any applicant for failing to provide this information. Even if the applicant volunteers this information, the proposed rule prohibits the contractor from relying on that information at any stage in the hiring process – including in determining the compensation for the individual if hired.

    The proposed rule mandates the inclusion of a specific clause in every job posting, notifying applicants of their rights: “Federal contractors and subcontractors may not inquire about or rely on an applicant’s compensation history to screen an applicant for employment or to determine the applicant’s pay for a position on or in connection with a Federal contract or subcontract, even when the information is offered without prompting.”

    B. Compensation Disclosure Mandate

    The proposed rule will require contractors to disclose the compensation to be offered in solicitations and advertisements for job openings placed by or on behalf of the contractor for any position to perform work on, or in connection with, the contract.

    The rule defines “work on or in connection with” broadly, including any work called for by the contract or work activities necessary to the performance of the contract, even if not specifically called for by the contract itself.

    For these designated positions, the contractor must disclose the salary or wages that it, in good faith, believes it will pay for the advertised position. The disclosure must also include a general description of the benefits and other forms of compensation also applicable to the job opportunity.

    As with the ban on compensation history, the proposed rule mandates the inclusion of a specific clause in every job posting: “The employer must also disclose the compensation for the position in all advertisements for the job opening.”

    Plus, the proposed rule also requires contractors to include contact information for the relevant government agency, directing applicants on how to submit a complaint if the contractor or subcontractor violates any requirements under the proposed rule.

    C. Applicability

    The rule is intended to apply sweepingly; the new rule will be imposed in all solicitations and contracts, with no exceptions for contracts below the simplified acquisition threshold or for commercial products and services, including commercially available off-the-shelf (COTS) items. Declining to make any exceptions based on contract or workforce size, the proposed rule states that “the benefits of pay equity and transparency requirements in this proposed rule are equally impactful in commercial and noncommercial settings as well as to large or small dollar contracts.”

    The requirements of the proposed rule would also apply to all subcontractors, at any tier, “with a principal place of performance within the United States including its outlying areas.”

    Takeaways

    • All federal contractors and subcontractors will be prohibited from asking any compensation history information and from using such information, even if volunteered by the applicant.
    • Compensation information is broadly defined by the rule. It is far more than just salary and wages, extending to other benefits such as vacation pay, insurance and retirement.
    • The proposed rule includes specific language that all federal contractors and subcontractors must include in the job postings for all positions to perform work on, or in connection with, the contract.
    • There are no exceptions to the broad application for contracts under the simplified acquisition threshold or for commercial items or services; all federal contractors will be subject to the clause. Plus, contractors will be required to flow down the rule to all subcontractors – again, no exceptions are provided.
    • Federal contractors should consider conducting a pay equity audit, together with legal counsel, to properly evaluate their compensation practices, implement appropriate remediation (if needed) and manage potential legal risks.

    For federal contractors and subcontractors operating in states that already impose these requirements, the proposed rule will be familiar. For all others, it will create novel challenges. All federal contractors and subcontractors will need to be aware of how the proposed clause defines such bans and disclosures as well as the incredibly broad application of these requirements.

    Authors

    Elizabeth Hummel

    Associate

    Chicago

    More insights

  • “Common Sense” Governs Tribal Sovereign Immunity Under Federal Contracting Program

    “Common Sense” Governs Tribal Sovereign Immunity Under Federal Contracting Program

    ARTICLE

    “Common Sense” Governs Tribal Sovereign Immunity Under Federal Contracting Program

    May 16, 2024

    Read time: 4 min

    Key takeaways
    Overview

    The US Court of Appeals for the Eleventh Circuit reversed and remanded a district court’s ruling, holding that waiver of sovereign immunity for claims related to a federal contracting program means the defendant, a sovereign Indian tribe, can be sued and that the district court failed to consider the valid and enforceable nature of the forum. AQuate II, LLC v. Jessica Tedrick Myers and Kituwah Global Gov’t Group, LLC, Case No. 22-12669 (11th Cir. May 1, 2024) (Grant, Abudu, Hull, JJ.)

    AQuate II is a business organized under the authority of the Alabama-Quassarte Tribal Town. Kituwah Services is organized under the authority of the Eastern Band of Cherokee Indians. Both tribal entities compete for and perform federal contracts under the Small Business Administration’s 8(a) Business Development program, which was created to help qualifying small businesses that are owned/controlled by “socially and economically disadvantaged” individuals/groups compete for federal procurement contracts. Jessica Myers, a former AQuate II employee, took a job as the director of administration for Kituwah and allegedly violated her confidentiality commitments by taking copies of contracts, proposals, personnel lists and other secret information. Myers also allegedly contacted her former colleagues at AQuate II to solicit information regarding bids for a federal contract and provided job offers to AQuate II employees contingent upon Kituwah winning the federal contract. AQuate II sued in federal district court, alleging that Myers breached her employment agreements and that she and Kituwah violated both the Defend Trade Secrets Act of 2016 and the Alabama Trade Secrets Act. (18 U.S.C. § 1836; Ala. Code § 8-27-1 et seq.) AQuate II requested a preliminary injunction, and Kituwah and Myers moved to dismiss.

    Enrollment in the 8(a) program requires qualifying businesses to agree to “sue and be sued” in US federal courts for “all matters relating to” the Small Business Administration, including its 8(a) program and related participation, loans and contract performance. (13 C.F.R. § 124.109(c)(1).) Kituwah invoked sovereign immunity and claimed it was not subject to suit in federal district court. AQuate II argued that Kituwah had waived its sovereign immunity with respect to claims relating to Kituwah’s participation in the 8(a) program. The district court granted the motion to dismiss, holding that Kituwah had not waived sovereign immunity for the trade secrets claims because AQuate II’s lawsuit did not “relate to” participation in the 8(a) program. The district court dismissed the same claims against Myers, finding that Kituwah was a necessary and indispensable party under Rule 19. Lastly, the district court dismissed the remaining breach of contract claim against Myers under forum non conveniens, concluding that the dispute resolution policy required that the claim be resolved in the Alabama-Quassarte Tribal Town court. The district court denied AQuate II’s motion for reconsideration, and AQuate II appealed.

    The Eleventh Circuit reversed and remanded, noting that under 1998 Supreme Court precedent, Kiowa Tribe of Oklahoma v. Mfg. Techs., “an Indian tribe is subject to suit only where Congress has authorized the suit, or the tribe has waived its immunity.” The burden is on AQuate II, as the party seeking to invoke federal jurisdiction, to show that Kituwah “expressly and unmistakably waived its right to sovereign immunity from suit.” The Eleventh Circuit held that AQuate II’s claims are “related to” Kituwah’s participation in the 8(a) program and that it “would defy common sense to hold otherwise” because Kituwah would not have used stolen trade secrets or unlawfully solicited information from current AQuate II employees but for the bid for the 8(a) program contract.

    Myers argued that she agreed with AQaute II to resolve disputes in the Alabama-Quassarte Tribal Town court, which was governed by a forum selection clause. The Eleventh Circuit reversed and remanded this issue, noting that the tribal court does not exist and requiring the district court to make a finding on enforceability of the forum selection clause under the circumstances.

    Authors
    More insights
    Endnotes

  • Revisiting Trade Secret Strategies Following the FTC’s Ban on Noncompete Agreements

    Revisiting Trade Secret Strategies Following the FTC’s Ban on Noncompete Agreements

    ARTICLE / CLIENT ALERT

    Revisiting Trade Secret Strategies Following the FTC’s Ban on Noncompete Agreements

    May 16, 2024

    Read time: 6 min

    Key takeaways
    Overview

    On April 23, 2024, in a move that will have significant ramifications for employment contracts and intellectual property (IP) rights, the Federal Trade Commission (FTC) issued a rule banning all future noncompete agreements nationwide with limited exceptions. The rule marks a pivotal moment for trade secret protection and enforcement strategies as it promises to reshape the relationship between employers and employees and impact safeguards for proprietary information.

    Noncompete agreements have long been used to temporarily restrict employees from working for a competitor or starting a competing business after leaving an employer. These agreements are often used to protect a company’s IP by prohibiting employees from taking and/or disclosing proprietary information, such as customer lists, to competitors.

    The FTC’s new ban on noncompete agreements requires employers to tailor their strategies for protecting valuable proprietary information.

    In depth

    Trade Secret Protection Strategies

    The FTC’s new rule should motivate employers to seek alternative measures to protect proprietary company information, including through trade secret enforcement. For many employers, however, trade secrets are often the most overlooked form of IP. Many employers are unaware that trade secrets are a valuable part of their IP portfolio that provides a competitive advantage. Almost any type of proprietary information can be a trade secret, so long as the information is valuable because it is not generally known or readily ascertainable by others. Trade secrets can include technical information, manufacturing processes, chemical formulas, recipes, specialized know-how, test data, customer lists and data, price lists, supplier information, strategic business plans, financial and marketing information, and virtually any other commercially valuable secret information.

    Noncompete agreements have commonly been used to protect an employer’s trade secrets from falling into the hands of a competitor. The FTC’s ban should encourage employers to analyze their current trade secret protection strategies and devise new and enhanced safeguards to sufficiently protect those trade secrets from improper disclosure by departing employees.

    Unless an employer takes “reasonable efforts” to protect a trade secret from improper disclosure, the employer can lose its right to prevent others from using the trade secret. Whether a company’s efforts are reasonable depends on evolving industry norms and the nature of the trade secret. Some protective measures to consider implementing include access control measures, password protection, encryption techniques, monitoring systems, document labeling and confidentiality agreements with third-party suppliers and customers. The efficacy of these measures should be regularly assessed, and potential vulnerabilities should be promptly addressed. Employers should consider other options as well, such as periodically updating company policies, revising employee handbooks and training employees on how to safeguard the company’s trade secrets.

    Employers should still use confidentiality and nondisclosure agreements (NDAs) to safeguard sensitive information as long as these agreements do not essentially function as de facto noncompete agreements. Such agreements should be carefully drafted to require that employees maintain the confidentiality of proprietary information both during and after their employment and prohibit all future use and disclosure of such information.

    Ultimately, deciding which protective measures are appropriate is a complex process that requires balancing appropriate secrecy with the practical realties of efficient business operations. It’s crucial that trade secret owners appropriately tailor measures to protect their valuable proprietary information. These assessments are case specific, and trade secret owners should consult legal counsel to ensure proper protections are in place.

    Trade Secret Enforcement

    The FTC’s ban will almost certainly increase the volume of trade secret litigation. Because the ban may make it more common for employees to leave their employers to work for their employer’s competitors, employers will be forced to threaten or pursue legal action more frequently against departing employees suspected of trade secret misappropriation – and in some instances, against the new employer. Under current state and federal laws, remedies for trade secret misappropriation include monetary damages, injunctive relief and reimbursement of attorneys’ fees.

    Conversely, hiring a new employee from a competitor also requires diligence to avoid being sued for trade secret misappropriation. To minimize misappropriation claims arising from hiring new employees, employers should maintain an explicit policy prohibiting the hiring of new employees from a competitor for the purposes of obtaining that competitor’s proprietary information. Employers should also seek to cultivate a work environment in which such hiring practices are clearly unacceptable. Additionally, employers should ensure that new hires understand and attest in writing that the use or disclosure of a prior employer’s proprietary information is strictly forbidden. Such efforts are particularly important when hiring multiple new employees from the same competitor. After new employees are hired, follow-up procedures should be implemented to ensure compliance with these policies and restrictions.

    When an employer or its new employee is accused of trade secret misappropriation, the employer should promptly investigate the allegations and preserve relevant electronic and physical evidence. The employer should also ensure that relevant files, communications and metadata are not altered or deleted. The employer should further consider implementing mitigation efforts, such as restricting the new employee’s access to the alleged proprietary information or reassigning the new employee to tasks unrelated to the alleged proprietary information. Each situation is unique and will require consultation with capable legal counsel to alleviate any further damage and protect the company’s interests.

    Once the investigation is complete, the company may seek to resolve the dispute through settlement discussions with the prior employer. If the attempt at informal resolution fails, however, the company should prepare strong defenses against the allegations. Common defenses against a trade secret misappropriation claim include proving (a) independent development, (b) that the alleged trade secret is not proprietary to the prior employer because it is reasonably ascertainable through other means, (c) that the prior employer failed to take reasonable measures to maintain secrecy of the alleged trade secret and (d) that the trade secret is not proprietary to the prior employer because it was lawfully acquired.

    Bottom Line

    The FTC’s ban on noncompete agreements has the potential to significantly impact trade secret protection by encouraging the adoption of alternative safeguards. While the full ramifications of the new rule remain to be seen, including whether it survives pending legal challenges, the rule represents a significant step toward changing the relationship between employers and employees and requires employers to reassess the efficacy of their current efforts to protect their trade secrets.

    Authors

    Amol Parikh

    Partner

    Chicago

    Brian Mead

    Partner

    Chicago

    Jodi Benassi

    Partner

    San Francisco

    More insights

  • Is it possible to “compare away” the right to information under data protection law?

    Is it possible to “compare away” the right to information under data protection law?

    ARTICLE

    Is it possible to “compare away” the right to information under data protection law?

    May 16, 2024

    Read time: 2 min

    Key takeaways
    Overview

    The HR News blog provides regular updates on recent developments in German employment law (in German). The latest blog post provides insights on “Is it possible to “compare away” the right to information under data protection law?”.

    Visit the blog and/or register now for regular HR NEWS updates (in German).

    In depth
    Authors

    Dr. Philip Uecker

    Associate

    Düsseldorf

    More insights

  • Supreme Court Permits Retrospective Relief for Timely Copyright Claims Under Discovery Rule

    Supreme Court Permits Retrospective Relief for Timely Copyright Claims Under Discovery Rule

    ARTICLE / CLIENT ALERT

    Supreme Court Permits Retrospective Relief for Timely Copyright Claims Under Discovery Rule

    May 14, 2024

    Read time: 5 min

    Key takeaways
    Overview

    On May 9, 2024, in a 6-3 decision, the Supreme Court of the United States affirmed the US Court of Appeals for the Eleventh Circuit’s prior ruling, holding that a plaintiff with a timely infringement claim under the discovery rule is entitled to damages regardless of when the infringement occurred. Warner Chappell Music, Inc. v. Nealy, Case No. 22-1078, 2024 WL 2061137 (U.S. May 9, 2024) (Kagen, J.) (Gorsuch, J., dissenting). This means the Copyright Act entitles a copyright owner to obtain monetary relief for any timely infringement claim no matter when the infringement occurred.

    In depth

    Section 507(b) of the Copyright Act includes a three-year statute of limitations that runs from the time the claim accrues. A claim may only accrue one time under the discovery rule. In 2014, in Petrella v. Metro-Goldwyn-Mayer, Inc., the Supreme Court held that the equitable doctrine of laches does not bar copyright claims that are otherwise timely under the three-year limitations period set forth in Section 507(b). Since that time, the circuits have been split on Petrella’s application – the Second Circuit strictly limited damages from copyright infringement to the three-year period before a complaint is filed whereas the Ninth and Eleventh Circuits permitted retrospective relief for infringement occurring more than three years before the lawsuit’s filing as long as the plaintiff’s claim is timely under the discovery rule.

    In 2018, Music Specialist, Inc. and Sherman Nealy (collectively, Nealy) filed a copyright infringement suit against Warner alleging Warner was using Nealy’s musical works based on invalid third-party licenses and in violation of 17 U.S.C. § 501. The alleged copyright infringement occurred more than 10 years before Nealy filed the present lawsuit. The district court denied Warner’s motion for summary judgment on statute of limitation grounds, finding that there was a genuine dispute of material fact regarding when Nealy’s claim accrual occurred. In a separate order, the district court certified for interlocutory appeal the issue of whether “damages in this copyright action are limited to the three-year lookback period as calculated from the date of the filing of the Complaint pursuant to the Copyright Act and Petrella.” Nealy appealed.

    The Eleventh Circuit concluded that where a copyright plaintiff has a timely claim for infringement occurring more than three years before the filing of the lawsuit, the plaintiff may obtain retrospective relief for that infringement. The Court found that Petrella focused on the application of 17 U.S.C. § 507(b) to claim accrual under the injury rule, not the discovery rule, and was therefore inapplicable. Warner appealed to the Supreme Court.

    Justice Kagan wrote for the majority, joined by Chief Justice Roberts and Justices Sotomayor, Kavanaugh, Barrett and Jackson. The Supreme Court affirmed the Eleventh Circuit’s decision, holding that a plaintiff with a timely infringement claim under the discovery rule is entitled to damages regardless of when the infringement occurred. The Supreme Court confirmed that Section 507(b) of the Copyright Act does not establish a separate three-year limit on recovering damages. As such, there is no time limit on monetary recovery and a copyright owner possessing a timely claim is entitled to damages for infringement no matter when the infringement occurred. The Supreme Court upheld the ruling in Petrella and distinguished the present case on the facts because “[u]nlike the plaintiff in Petrella, Nealy has invoked the discovery rule to bring claims for infringing acts occurring more than three years before he filed suit.” The Supreme Court’s ruling here overruled the Second Circuit’s holding in Sohm v. Scholastic Inc., 959 F.3d 39 (2d Cir. 2020), which limited monetary recovery to the three years prior to initiation of the lawsuit, and clarifies the circuit split between the courts.

    Justice Gorsuch wrote the dissent, joined by Justices Thomas and Alito. The dissent argued that the Copyright Act does not tolerate a discovery rule and would have preferred to dismiss the case “as improvidently granted and awaited another squarely presenting the question whether the Copyright Act authorizes the discovery rule.”

    Practice Note: The Supreme Court’s ruling incentivizes copyright owners to pursue older infringements, which may lead to an uptick in lawsuits as plaintiffs review histories to discover potential infringements. On the other hand, this ruling impacts defendants by exposing them to liability for infringements that occurred well beyond the three-year statute of limitations, provided these infringements are discovered within three years prior to filing the lawsuit.

    For more information on this topic and/or legal advice, please contact your regular McDermott lawyer or one of the listed authors.

    Authors

    Amol Parikh

    Partner

    Chicago

    More insights

  • HHS Final Rule: Nondiscrimination on the Basis of Disability in Programs or Activities

    HHS Final Rule: Nondiscrimination on the Basis of Disability in Programs or Activities

    ARTICLE / CLIENT ALERT

    HHS Final Rule: Nondiscrimination on the Basis of Disability in Programs or Activities

    May 14, 2024

    Read time: 12 min

    Key takeaways
    Overview

    For the first time in nearly 50 years, the US Department of Health and Human Services (HHS) Office for Civil Rights (OCR) has finalized revisions to regulations implementing Section 504 of the Rehabilitation Act of 1973, which protects against discrimination on the basis of disability as it applies to programs and activities that receive federal financial assistance from HHS (hereinafter recipients). The final rule, Nondiscrimination on the Basis of Disability in Programs or Activities Receiving Federal Financial Assistance, will take effect July 8, 2024, and largely incorporates all of the changes in the proposed rule. Here, we provide an overview of the final rule’s key points and the requirements that affected parties will need to prepare for.

    In depth

    HHS implemented Section 504 into rules applicable to health and human services programs in 1977. Those rules remained largely unchanged over the decades, leading to some inconsistencies with other federal civil rights laws. Recognizing the impact that discrimination has played in denying individuals with a disability an equal opportunity to participate fully in healthcare programs, HHS proposed a sweeping set of rules on September 14, 2023, and finalized them on May 9, 2024.

    The historic final rule provides robust civil rights protections for a broad array of people with disabilities who seek services from more than 100 federally funded health and human services programs, thereby affecting hospitals; healthcare providers participating in the Children’s Health Insurance Program, Medicare and Medicaid; state and local human or social service agencies; senior services facilities and child placement agencies.

    The scope of the final rule’s application is potentially quite broad. Going forward, entities whose only source of federal funds is Medicare Part B are likely to also be required to comply with Section 504 in light of new HHS rules finalized pursuant to Section 1557 of the Affordable Care Act. Likely because requirements under Section 504 are similar to requirements under the Americans with Disabilities Act of 1990 (ADA), most of the components of HHS’s Notice of Proposed Rulemaking (NPRM) were consistent with what recipients are already doing, leading to only around 5,000 generally positive comments. Accordingly, the final rule closely follows the language of the NPRM.

    This On the Subject highlights six areas addressed in the final rule that should be given special consideration for their potential impact on recipients’ current operations: medical treatment, value assessment methods, child welfare programs and activities, technology-based accessibility, accessible medical equipment and integration.

    Medical Treatment

    HHS observes in the proposed rule that pervasive discrimination on the basis of disability in accessing medical care leads to significant health disparities and poorer health outcomes for individuals with disabilities. The final rule ensures that medical treatment decisions by those that receive HHS funding are not based on stereotypes or preconceived notions about individuals with disabilities, such as quality of life.

    The final rule sets forth specific prohibitions on discrimination against those with disabilities by recipients of HHS funding. It expressly prohibits the denial of medical treatment based on bias or stereotypes, including a belief that a person with a disability is a burden on others because of their disability. It also prohibits the denial of treatment for a symptom or condition unrelated to the individual’s disability. A recipient may not, on the basis of disability, provide a medical treatment to an individual with a disability where it would not provide the same treatment to an individual without a disability unless the disability has an effect on the treatment.

    Additionally, the final rule expounds on prohibitions related to discriminatory medical treatment by explaining circumstances when medical treatment may be withheld, such as when:

    • A medical professional denies an individual with a disability a specific treatment for legitimate purposes, such as futility or the disability rendering the individual unqualified
    • The provider does not receive consent from the patient or authorized representative to undergo a particular treatment
    • The patient received information regarding the implications of different courses of treatment based on current medical knowledge or the best available objective evidence and the patient provides informed consent to forego a procedure.

    Although a provider may communicate concerns that a treatment may not improve the quality of life of a patient with a disability or would render their quality of life so low as to not be worth living, the provider may not pressure or coerce the patient or representative or discriminate on the basis of disability in the manner in which the provider seeks authorization to withdraw or scale down treatment. HHS observes that an individual with a disability may take longer to respond to some treatment modalities or may require long-term support but can nevertheless survive and thrive, making a provider’s determination of value of life discriminatory in certain circumstances.

    Value Assessment Methods

    Under the proposed rule, HHS recommended that a recipient may not use any measure, assessment or tool that discounts the value of extending the life of an individual with a disability as a means to deny or afford an unequal opportunity to access otherwise entitled services. HHS requested comments on when value assessment methods may play a role in determining whether a particular intervention, such as a medicine or treatment, might be appropriate. Commenters observed that value assessments are an increasingly significant tool for cost containment and quality improvement efforts and gave several examples of value assessments that should be allowed or prohibited.

    HHS decided not to authorize or prohibit specific types of value assessments in the final rule and instead states that it will continue to allow nondiscriminatory value assessments depending on the circumstances where they are used. If such an assessment devalues extending the life of an individual merely because of a disability, HHS would continue to prohibit that assessment’s use in such circumstances.

    Child Welfare Programs and Activities

    The final rule discusses the wide range of discriminatory barriers that children, parents, caregivers, foster parents and prospective parents with disabilities may encounter while navigating child welfare systems. These barriers may include failing to provide reasonable modifications, failing to place children in the most integrated setting appropriate for their needs, or stereotypes about whether individuals with disabilities can safely care for a child.

    The final rule clarifies that Section 504’s nondiscrimination provisions apply to HHS-funded child welfare programs and activities and should be interpreted to protect all individuals with a disability seeking access to such services, including children, biological or adoptive parents, caregivers, guardians, foster parents or prospective parents.

    HHS observes that child welfare agencies and providers are obligated by law to ensure the safety and wellbeing of children in the welfare system; however, the decision of whether a caregiver can provide for a child’s safety and wellbeing should be based on facts applicable to the individual rather than stereotypes about individuals with disabilities. To that end, the final rule clarifies that it does not narrow or limit recipients’ existing and long-standing obligations under other civil rights statutes, including the ADA. Rather, the Section 504 final rule sets forth additional prohibitions specific to child welfare programs and services that are often used to:

    • Deny a qualified parent with a disability custody, control or visitation to a child
    • Deny a qualified parent with a disability the opportunity to benefit from services provided by a child welfare agency
    • Terminate parental rights or legal guardianship of a qualified individual with a disability
    • Deny a qualified caregiver, foster parent, companion or prospective parent with a disability the opportunity to participate or benefit from child welfare programs based on discriminatory criteria, including IQ tests or algorithms
    • Require children, on the basis of disability, to be placed outside the family home through custody relinquishment, voluntary placement or other forfeiture of parental rights in order to receive necessary services.

    HHS observes that this is not an exhaustive list, and all HHS-funded child welfare recipients are prohibited from discriminating on the basis of disability in all of their programs and activities.

    Technology-Based Accessibility

    As technology continues to provide new ways to deliver health and human services programs and activities, HHS considers it vital to ensure that those methods are readily accessible to and usable by individuals with disabilities. Recognizing that the use of algorithms, automated decision-making and artificial intelligence is a growing technology that may have unintended disability discrimination consequences, HHS requests comments on whether OCR should issue guidance or consider future rulemaking in addition to the protections established through final rules implementing Section 1557.

    For other more established technologies, such as websites and mobile applications, the final rule requires recipients who use such technologies to comply with the Web Content Accessibility Guidelines (WCAG) 2.1 AA technical standards if accessing these technologies is necessary for a qualified individual with a disability to fully participate in the recipient’s programs and services.

    Specifically, the final rule requires that beginning May 11, 2026, recipients with 15 or more employees must ensure that the web content and mobile applications they provide or make available to patients comply with Level A and Level AA requirements specified in WCAG 2.1. There is a safe harbor for compliance if a recipient can demonstrate that compliance would result in a fundamental alteration to the program or activity or an undue financial, administrative or legal burden.

    Additionally, recipients may use conforming alternate versions of web content only where it is not possible to make web content directly accessible because of technical or legal limitations.

    The following are exempt from the final rule’s accessibility requirements:

    • Archived web content
    • Preexisting conventional electronic documents
    • Content posted by a third party because of contractual, licensing or other arrangements with the recipient
    • Individualized password-protected documents or otherwise secured conventional electronic documents
    • Preexisting social media posts that were posted before the recipient was obligated to comply with the final rule

    Additionally, a recipient may make alternate versions of web content that meet WCAG 2.1 standards when it’s not possible to make the original web content directly accessible because of technical or legal limitations.

    Accessible Medical Equipment

    Perhaps the most impactful changes finalized by HHS are aimed at overcoming the barriers experienced by individuals with disabilities because of inaccessible medical equipment. Exam tables that are not height adjustable, mammography machines that require a person to stand, and weight scales that do not accommodate wheelchairs all result in inequities and exclusion from basic health services for individuals with disabilities, exacerbating the risk for poorer health outcomes.

    The final rule implements standards for all newly purchased, leased or otherwise acquired medical diagnostic equipment (MDE), requiring all newly acquired equipment to meet the US Access Board’s Standards for Accessible MDE (effective 60 days after the final rule’s publication date). Additionally, the final rule provides scoping requirements for various programs or activities. Recipients using MDE in physician offices, clinics, emergency rooms, hospitals, outpatient facilities and multiuse facilities must have at least 10% of the total number of units – but no fewer than one unit – of each type of equipment in use meet the Standards for Accessible MDE. Facilities that specialize in the treatment of conditions that affect mobility must have at least 20% – but no fewer than one unit – of each type of equipment in use meet the Standards for Accessible MDE. Facilities with multiple departments that utilize MDE must disperse the equipment in a manner that is proportionate by department, clinic or specialty.

    Furthermore, the final rule establishes that recipients must acquire at least one accessible exam table and one accessible scale within two years of the date that is 60 days after the final rule is published. This provision of the final rule does not require a recipient to take any action that it can demonstrate would result in a fundamental alteration in a program or activity or undue financial and administrative burdens.

    Lastly, HHS sets standards for existing MDE, stating that the final rule does not necessarily require a recipient to make each of its existing pieces of MDE usable by individuals with disabilities if other methods are effective in achieving compliance with Section 504. However, in such a circumstance, the recipient must reassign services to alternate accessible locations, establish home visits, purchase or acquire accessible MDE, or enact other methods that would make its programs and activities readily accessible and usable by individuals with disabilities.

    Integration

    The existing Section 504 rules require programs and activities to be administered in the most integrated setting appropriate to the needs of a person with a disability. Within the final rule, HHS clarifies that integration should be interpreted as the setting that provides individuals with disabilities the opportunity to fully interact with non-disabled persons. These settings empower individuals to live, work and receive services in the greater community – like individuals without disabilities.

    Conclusion

    Although this is not a comprehensive list of all the updates and requirements set forth in the final rule, this article demonstrates the major steps HHS has taken to further equity in healthcare for individuals with disabilities. Reflecting over 50 years of advocacy by the disability community, the final rule advances the promise of the Rehabilitation Act and helps to protect people with disabilities from being subjected to discrimination in any program or activity receiving HHS funding.

    Most provisions of the final rule require compliance by July 8, 2024, except (i) the obligation to acquire accessible examination tables and weight scales, which is required by July 8, 2026, and (ii) converting websites and mobile applications to WCAG 2.1 standards by May 11, 2026, for recipients with more than 15 employees and by May 10, 2027, for recipients with less than 15 employees.

    For more information, we recommend reviewing our previously published deep dive into the NPRM or contacting either the authors or your regular McDermott lawyer.

    Authors

    Joshua Neumann

    Associate

    Chicago

    More insights

  • The New UK Securitisation Regime: A First Step

    The New UK Securitisation Regime: A First Step

    ARTICLE / CLIENT ALERT

    The New UK Securitisation Regime: A First Step

    May 14, 2024

    Read time: 7 min

    Key takeaways
    Overview

    Final rules published by FCA and PRA on UK securitisation parties

    On 30 April 2024, the FCA and PRA each published its final rules on the UK securitisation framework, using the powers delegated to each of them under the Securitisation Regulations 2024 SI (together, the “New UK Rules”). These rules contain the much awaited detail surrounding how the UK regulators will change key areas of the onshored version of the current UK securitisation regulation (the “Existing UK Rules”) and derogate from its EU equivalent (the “EU Securitisation Regulation”).

    The New UK Rules will come into effect on 1 November 2024 (the “Implementation Date”). However, the existing regime will continue to apply for securitisations issued prior to the implementation of the new rules, except where a UK institutional investor delegates its due diligence requirements to a non-UK authorised AIFM (as discussed below).

    Changes from the draft proposals

    The New UK Rules are: (1) broadly in line with each other, to the extent they relate to the relevant firms under the FCA/PRA’s legislative purview; and (2) not significantly changed from the Existing UK Rules nor from their respective draft rules published in the summer of 2023, given the stated intent by the FCA, PRA and His Majesty’s Treasury was not to drive a change in the substance of current policy. The FCA and PRA have, however, made some changes in the following areas since their respective draft rules were published:

    • Clarification that information must be provided either “before pricing” or at the time of an investor’s “commitment to invest in” a securitisation under the due diligence and transparency requirements. In particular that for primary market investments, documentation provided on pricing can be in draft or initial form, with final versions to be made available within 15 days after closing of the transaction; whereas for secondary market purchases the documentation should be provided in final form before the commitment to invest;
    • Distinction between secondary and primary market investments so secondary market investors are not required to conduct diligence on information which is no longer relevant;
    • Clarification that a UK institutional investor may delegate its due diligence to another investor, which may or may not be an ‘institutional investor’ as defined for the purposes of the New UK Rules, provided that the UK institutional investor retains the responsibility for compliance with the due diligence requirements where the delegate is not a UK institutional investor;
    • Clarification that appointment of a UK third party verifier to assess compliance with the UK STS criteria will not affect the liability of the originator, sponsor or SSPE in respect of their obligations;
    • Alignment of the PRA rules with the equivalent FCA rules on transparency requirements allowing PRA firms to disclose data in an aggregated or anonymised form (or in relation to underlying documentation, as a summary) in circumstances where UK law relating to confidentiality and/or processing of personal data relating to customer, original lender or debtor information do not allow more ‘granular’ disclosures; and
    • Introduction of transitional provisions for pre-Implementation Date securitisations, see further below.

    Other points to highlight

    As a result of the New UK Rules coming into effect on the Implementation Date we have summarised certain key considerations for clients below (having also taken into account the unchanged draft proposals by the FCA and PRA in 2023 which are now reflected in the New UK Rules):

    • The so called originator “sole purpose” or “entity of substance” test under the New UK Rules differs from its EU Securitisation Regulation counterpart (which otherwise has been largely mirrored) where the FCA and PRA have adopted the draft language proposed by the EBA in 2018 rather than the EU Final Risk Retention RTS. Under the New UK Rules:
      • The stated factors are to be “taken into account” rather than act as requirements to fulfil the safe harbour which they do under the EU Final Risk Retention RTS, for an originator to satisfy the test; and
      • When considering whether the risk retainer relies on the exposures to be securitised, on any retained interest, or corresponding income from such exposures and interest there is no reference to such being its “sole or predominant source of revenue”.
    • The requirement under the Existing UK Rules for UK institutional investors to receive “substantially the same” information as that contained in the FCA reporting templates where a UK investor is participating in a non-UK securitisation has been removed. The requirement to receive certain key information (in a non-prescibed form) such as the transaction documents and quarterly investor reports including the key economics of the deal and the exposures, will apply to UK investors in all securitisations;
    • The use of a non-refundable purchase price discount for calculating the retention of non-performing securitisations was included in the New UK Rules, allowing the 5 per cent retention requirement to be measured at market value of the portfolio at the time of the securitisation rather than the full notional value of the financing (or the “par” value);
    • Whereas the EU rules lift the prohibition on selling the retained interest where the retainer, for legal reasons beyond its control and beyond the control of its shareholders, is unable to continue acting as a retainer, the UK rules on the other hand only provide relief upon the insolvency of the retainer or where retention is on a permitted consolidated basis;
    • The ability for the risk retainer to use its retained interest as collateral for secured funding purposes including those which involve a sale, transfer or other surrender of all or part of the rights, benefits or obligations thereof, has been preserved provided that such use as collateral does not result in a transfer of credit risk from the retainer to a third party of the retained interest;
    • The retainer may hedge the net economic interest where the hedge is undertaken prior to the securitisation as a prudent element of credit granting or risk management and does not create a differentiation for the retainer’s benefit between the credit risk of the retained securitisation positions or exposures and the securitisation positions or exposures transferred to investors;
    • There is no need for risk retention in relation to securitisations of an entity’s own liabilities (e.g. own issued covered bonds);
    • Originators may select assets to be transferred to the SSPE with ex ante a higher than average risk profile than assets remaining on the balance sheet provided that this is clearly communicated to investors or potential investors;
    • Retranching by the securitisation’s originator of an issued tranche into contiguous tranches shall not constitute a securitisation; and
    • the relevant reporting templates have also been published by the FCA and PRA.

    Future developments

    The FCA and the PRA have indicated that they both intend to consult further on potential changes to the securitisation framework in Q4 2024 and early 2025, although timings are subject to change. Areas we would expect to see up for discussion in the next round include the definition of public and private securitisations and the related reporting regime along with a general aim of making the reporting regime more proportionate.

    It should always be borne in mind that the whole point of devolving the onshored legislation into the FCA and PRA rulebooks was to enable a more rapid response by regulators, without involving legislative change, to changing markets and specific events as well as changes implemented in the closely tied EU regulations. Whether this eventually leads to a wider shift from the EU Securitisation Regulation remains to be seen, but it has certainly been hinted at.

    Looking further into the (perhaps distant) future, it is possible to imagine much more significant deviations from the EU rules and the existing UK rules being implemented, whether that could be changes to the actual definition of “securitisation”, the introduction of ESG elements or a widening of the STS criteria to permit managed CLO transactions to qualify, perhaps…

    Authored by Stuart Axford, Martin Sharkey and James Zhu.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.

    In depth
    Authors

    Stuart Axford

    Partner

    London – One Eagle Place

    Martin Sharkey

    Partner

    London – One Eagle Place

    James Zhu

    Senior Associate

    London – One Eagle Place

    More insights

  • GDPR compensation: No liability for companies in the event of employee misconduct?

    GDPR compensation: No liability for companies in the event of employee misconduct?

    ARTICLE

    GDPR compensation: No liability for companies in the event of employee misconduct?

    May 13, 2024

    Read time: 2 min

    Key takeaways
    Overview

    The HR News blog provides regular updates on recent developments in German employment law (in German). The latest blog post provides insights on “GDPR compensation: No liability for companies in the event of employee misconduct?”.

    Visit the blog and/or register now for regular HR NEWS updates (in German).

    In depth
    Authors

    Dr. Philip Uecker

    Associate

    Düsseldorf

    More insights

  • Planned Digitalization of Company Law: The EU Company Certificate

    Planned Digitalization of Company Law: The EU Company Certificate

    ARTICLE / CLIENT ALERT

    Planned Digitalization of Company Law: The EU Company Certificate

    May 13, 2024

    Read time: 2 min

    Key takeaways
    Overview

    In cross-border legal transactions, players often encounter the problem that national commercial register data is difficult to compare. The lack of reliable register information in some member states also leads to a time-consuming information procurement process and inevitably drives up costs.

    The European Commission responded to this problem back in March 2023 with a proposal for a Digitalization Directive II, which is intended to further develop digitalization in company law (“Commission draft”). A key element of the proposed Digitalization Directive II is the introduction of an EU Company Certificate (“EU Company Certificate”). In this article, Dr. Philipp Grenzebach, Dr. Frederic Peine and Annabelle Rau explain the planned EU company certificate and its potential impact on cross-border legal transactions within the internal market. (German Article)

    In depth
    Authors

    Dr. Philipp Grenzebach

    Partner

    Düsseldorf, Frankfurt

    Annabelle Juliette Rau

    Associate

    Cologne

    More insights

  • New DOJ Task Force to Target ‘Multisided Giants’ in Healthcare

    New DOJ Task Force to Target ‘Multisided Giants’ in Healthcare

    ARTICLE

    New DOJ Task Force to Target ‘Multisided Giants’ in Healthcare

    May 10, 2024

    Read time: 4 min

    Key takeaways
    Overview

    The US Department of Justice’s (DOJ) announcement of the formation of a new healthcare task force signals an even stronger emphasis on addressing competition issues in the healthcare industry. Large, multisided platforms involved in multiple sectors (e.g., insurance companies acquiring physician practices and/or essential healthcare IT and data services) are a key target for enforcement.

    In depth

    WHAT HAPPENED:

    • On May 9, 2024, the DOJ announced the formation of the Antitrust Division’s Task Force on Health Care Monopolies and Collusion (HCMC). The HCMC will be tasked with guiding and developing policy advocacy and conducting investigations – and ultimately civil and criminal enforcement actions –in healthcare markets.
    • US Assistant Attorney General Jonathan Kanter stated that the HCMC “will identify and root out monopolies and collusive practices that increase costs, decrease quality and create single points of failure in the health care industry.” The press release specifically identified the following non-exhaustive set of issues that will be priority areas for the HCMC: payer-provider consolidation, serial acquisitions, labor, quality of care, medical billing, healthcare IT services, and the access to and misuse of healthcare data.
    • In announcing the formation of the task force at a Washington Post Live event, Kanter highlighted the changing nature of the healthcare marketplace. In what he coined the “platformization of healthcare,” patients and consumers now interact with “multisided giants, intermediaries that have a coordinated stack of businesses that flow together, including payers, including providers, including PBMs, claims processing, banks” which have become the “gatekeepers of our healthcare system.” According to Kanter, it is crucial that the Antitrust Division adapt its enforcement policies and strategies in healthcare to reflect these new market realities.
    • The HCMC will be led by Katrina Rouse, an antitrust prosecutor at the DOJ since 2011 who previously served as chief of the Defense, Industrials, and Aerospace Section and a trial attorney in the Healthcare and Consumer Products Section. Rouse will oversee a team of civil and criminal prosecutors, economists, experts in healthcare and technology, data scientists, investigators and policy advisors.

    WHAT THIS MEANS:

    • The antitrust enforcement agencies have used similar task forces in the past to focus resources and accumulate subject matter expertise. For example, the DOJ’s Procurement Collusion Strike Force has been successful at investigating and pursuing government contracting cases.
    • The launch of the HCMC reflects the antitrust enforcement agencies’ increasing efforts to respond to changing dynamics in the healthcare space and address the potential harmful results of these changes on patients, healthcare workers and communities. In March 2024, the DOJ, Federal Trade Commission (FTC) and US Department of Health and Human Services (HHS) jointly launched a cross-government inquiry into the increasing role of private equity firms in healthcare transactions and whether such firms prioritize maximizing profits at the expense of healthcare quality and affordability.
    • Of note, the DOJ, rather than the FTC, typically investigates mergers involving health plans and contracting issues among health plans and providers. Therefore, healthcare industry participants, including health plans, hospitals, physician practices, IT and data companies, should be increasingly vigilant with their antitrust compliance efforts given the newly launched task force’s direct focus on monopolization and collusive practices in this space.
    • Companies who believe they are being harmed by consolidation and collusion in any aspect of the healthcare industry also have the opportunity to raise these issues offensively by reaching out to the HCMC. The DOJ, FTC and HHS previously announced a portal – healthycompetition.gov – through which the public may report suspected anticompetitive practices in the healthcare industry.
    Authors

    Stephen Wu

    Partner

    Chicago

    Ashley M. Fischer

    Partner

    Chicago

    Daniel Powers

    Partner

    Washington, DC

    Noah Feldman Greene

    Partner

    Washington, DC

    More insights
    Endnotes